Fagron, the leading global player in pharmaceutical compounding, is pleased to announce two strategic acquisitions that further strengthen its global footprint and diversify its capabilities. These ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Fagron (ENXTBR:FAGR) has completed the acquisition of Vepakum, expanding its ...
MIAMI--(BUSINESS WIRE)--Fagron North America, a leading supplier of compounded medications to hospital pharmacies and patients, will open one of the largest 503B human drug outsourcing facilities in ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Gallipot, the U.S. leader in creating and supplying compounding products and services for pharmacists, officially has become Fagron. Fagron is the global one-stop ...
Fagron, the leading global player in pharmaceutical compounding, announces the successful completion of its acquisition of Vepakum in Latin America. The transaction, announced in December 2025, was ...
PHOENIX--(BUSINESS WIRE)--Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D pharmaceutical printing, delivery systems, and ...
Nazareth (Belgium)/Rotterdam (The Netherlands), 12 January 2026 - 7:00 AM CET Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America Fagron, the leading ...
Nazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 - 7:00 AM CET Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone Fagron, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results